Shares outstanding · 2015–2025
Syndax Pharmaceuticals shares outstanding
87.4M+2.0% · FY2025
Syndax Pharmaceuticals (SNDX) reported 87.4M in shares outstanding for fiscal 2025, +2.0% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 87.4M | +2.0% | Open → |
| FY20242024-12-31 | 85.7M | +1.0% | Open → |
| FY20232023-12-31 | 84.8M | +24.5% | Open → |
| FY20222022-12-31 | 68.1M | +23.9% | Open → |
| FY20212021-12-31 | 55.0M | +14.8% | Open → |
| FY20202020-12-31 | 47.9M | +76.4% | Open → |
| FY20192019-12-31 | 27.1M | +9.3% | Open → |
| FY20182018-12-31 | 24.8M | +1.8% | Open → |
| FY20172017-12-31 | 24.4M | +33.9% | Open → |
| FY20162016-12-31 | 18.2M | +21,219.3% | Open → |
| FY20152015-12-31 | 85,440 | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +100.0%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Syndax Pharmaceuticals shares outstanding |url=https://companiesranked.com/en/company/syndax-pharmaceuticals/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Syndax Pharmaceuticals shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/syndax-pharmaceuticals/shares-outstandingBibTeX
@misc{companiesranked-en-company-syndax-pharmaceuticals-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Syndax Pharmaceuticals shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/syndax-pharmaceuticals/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-332750 · August 4, 2026
{{cite web |title=Syndax Pharmaceuticals shares outstanding — 10-Q (0001193125-26-332750) |url=https://www.sec.gov/Archives/edgar/data/1395937/000119312526332750/sndx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.